Fig. 1From: Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TCCumulative incidence of SARS-CoV-2 infection after administration of AZD7442Back to article page